Greek Health Minister to speak at Cannabis Europa London on Greece’s groundbreaking new medical cannabis programme, joined by Curaleaf executive...
A crowdfunder aims to raise £20,000 to undertake public relations and promotional activity around the existence and benefits of prescription cannabis.
Researchers have highlighted the need for greater public health messaging around the risks of cannabis use disorders.
The move will enable individuals with conditions such as anxiety, ADHD or PTSD to access treatment through Treat It clinic.
Adam Kavalier PhD, scientific director of Anthera Pharmaceuticals, explores what we know about medical cannabis in the treatment of PTSD.
Nathan Williams was pulled over by the same police officer just months after a previous case against him was dismissed.
Bundesrat votes in favour of CanG, with law set to come in on 1 April.
Curaleaf International, a market-leading global cannabis company, has been announced as the Headline Partner for Cannabis Europa, scheduled to take place in London on 25-26 June,...
Via Business of Cannabis Portugal’s cannabis regulator has approved three new cannabis preparations for its medical cannabis programme, marking the first expansion since 2021. Since voting...
The pilot in canton Zurich will include up to 7,500 participants and is the first to include a randomised control trial as part of the research.
The first study of its kind has found cannabis to be beneficial in the treatment of female orgasm disorder.